Intestinal screening of carbapenem-resistant Enterobacteriaceae (CRE) bacteria in patients with end-stage liver disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047284

Enrollment

Unknown

Registered

2021-06-11

Start date

2021-06-11

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage liver disease

Interventions

Case series:No

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients that meet the definition of decompensated cirrhosis or Liver failure according to the Guidelines for the Diagnosis and Treatment of Liver Failure in China; 2. Aged 18 to 80 years.

Exclusion criteria

Exclusion criteria: Those who refuse to comply with the study arrangement and sign the informed consent form or other circumstances that the researcher judges are not suitable for inclusion.

Design outcomes

Primary

Measure	Time frame
Colonization rate of carbapenem-resistant enterobacteriaceae in patients with end-stage liver disease;Risk factors for carbapenem-resistant enterobacteriaceae colonization;	—

Countries

China

Contacts

Public ContactLiu Jing

The Third Affliated Hospital of Sun Yat-Sen University

jingliu_1203@hotmail.com+86 13556051920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026